Mark Alexander Schobel - Chief Innovation/Tech Officer, Aquestive Therapeutics, Inc

As of March 15, 2021


Mark Alexander Schobel Net Worth

  • Net worth is estimated to be at least $5.13M
  • Owns at least 837,000 units of Aquestive Therapeutics, Inc stock
  • Sold an estimated value of $1.63M in the last 3 years at Aquestive Therapeutics, Inc

Mark Alexander Schobel Trading

  • Largest purchase of shares was 2,000 units , worth over $17.38K on December 10, 2018
  • Largest sale of shares was 80,000 units , worth over $308K on May 4, 2020
  • In total has made about 29 transactions over 3 years
  • Usually trades in March, with the busiest year in 2020 and 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Mark Alexander Schobel Mailing Address

  • Mailing address is 30 Technology Drive Warren NJ 07059 NJ

Aquestive Therapeutics, Inc Insider Trading

  • The most recent transaction was 35,000 units sold on February 10, 2021 by Mark Alexander Schobel worth over $236.25K
  • In the last 3 years, insiders at Aquestive Therapeutics, Inc sold an estimated value of $2.35M and bought an estimated value of $2.98M
  • The most active traders are Mark Alexander Schobel, Chief Innovation/Tech Officer,  Keith Kendall, CEO and President,  and Daniel Barber, SVP-Chief Operating Officer
  • Insider trading is most common in March, with the busiest year in 2019

Aquestive Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1